Tamoxifen-induced growth of leiomyomas: A case report

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 41, Issue 2, 1996, Pages 119-120

  Kang, Justin ^a   Baxi, Laxmi ^a,c   Heller, Debra ^a,b  

^a Sloane Hospital ^*  (United States)

^b Division of Obstetrics   (Singapore)

^c Department of Orthopaedic Surgery   (United States)

Author keywords

leiomyoma; postmenopause; tamoxifen

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; TAMOXIFEN;

AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CASE REPORT; CLINICAL FEATURE; FEMALE; HOT FLUSH; HUMAN; LEUKOPENIA; NAUSEA; POSTMENOPAUSE; PRIORITY JOURNAL; THROMBOCYTOPENIA; UTERUS MYOMA; UTERUS SURGERY; VAGINA DISCHARGE; VOMITING;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; HUMANS; LEIOMYOMA; POSTMENOPAUSE; TAMOXIFEN; UTERINE NEOPLASMS;

EID: 0030050436     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Dilts PV Jr, Hopkins M, Chang A, et al. Rapid growth of leiomyoma in patients receiving tamoxifen. Am J Obstet Gynecol 1992;166:167-168
2. Lumsden M, West C, Baird D: Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids. Clin Endocrinol 1989;31:335-43